The results showed notably increased cell migration, invasion (Fig. 5a, Supplementary Fig. S10A), and HUVEC migration (Supplementary Fig. S10B and C) in IL-6-treated GFP-CPAP-HCC stable cells. This evidence concerns the gene IL6 and hepatocellular carcinoma.